CNBC Africa

News

VACCINES TO FIGHT NEW VARIANTS SHOULD BE AVAILABLE BY THIRD QUARTER, SAYS SHABIR MADHI, LEAD INVESTIGATOR FOR OXFORD/ASTRAZENECA VACCINE TRIAL IN SOUTH AFRICA

PUBLISHED: Tue, 09 Feb 2021 17:59:40 GMT

VACCINES TO FIGHT NEW VARIANTS SHOULD BE AVAILABLE BY THIRD QUARTER, SAYS SHABIR MADHI, LEAD INVESTIGATOR FOR OXFORD/ASTRAZENECA VACCINE TRIAL IN SOUTH AFRICA

(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html

RELATED
FEATURED